“Health Canada received Moderna’s license application on October 12, 2020, and, after an independent and comprehensive review of the evidence, concluded that Moderna’s vaccine meets the Department’s stringent safety requirements,” efficiency and quality, ”the government agency said in a statement.
Canada thus becomes the second country in the world to approve Moderna’s remedy, after the United States.
The Canadian government earlier this month reached an agreement with the U.S. pharmaceutical company to ship some 168,000 doses early by the end of the year, bringing the total doses delivered to Canada by 2021 to 417,000.
Moderna vaccine is taken in two doses, a few weeks apart, like the Pfizer / BioNTech vaccine. But Moderna’s formula can be stored at -20 ° C, and not -70 ° C like the remedy from Pfizer, which forced the group to develop specific containers for transport.
As this product is easier to handle, priority will be given to aboriginal communities, isolated regions as well as Canadian territories which await their turn.
The Moderna vaccine is indicated for people 18 years of age and older, but the pharmaceutical company is continuing clinical studies with children 12 years and older. Health Canada indicates that the indication may be revised in the future to include this age group, “if the data from the studies in question are conclusive”.